NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001459

Registered date:29/10/2008

A phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer (JCOG0702)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedT2N0M0 non-small cell lung cancer
Date of first enrollment2008/10/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Stereotactic body radiotherapy

Outcome(s)

Primary Outcomeincidence of Grade 2 or more radiation pneumonits within 180 days after stereotactic radiotherapy
Secondary Outcomeoverall survival, 3-year survival, progression free survival, local progression free survival, 3-year local progression free survival, event free survival, pattern of failure, incidence of Grade 3 or more radiation pneumonitis, adverse events, severe adverse events

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. apparent interstitial pneumonitis and fibrosis 2. active inflamation without oral drugs 3. double cancer 4. pregnancy 5. psychiatric disorder 6. steroid administration 7. oxygen administration 8. fever of 38.0 degrees centigrade or higher 9. narcotics administration for coughing

Related Information

Contact

public contact
Name Rikiya Onimaru
Address North14 West5, Kitaku, Sapporo, Hokkaido, 060-8648 Japan Japan
Telephone 011-706-5977
E-mail JCOG_sir@ml.jcog.jp
Affiliation JCOG0702 Coordinating Office Hokkaido University Hospital Radiology Division
scientific contact
Name Hiroki Shirato
Address North14 West5, Kitaku, Sapporo, Hokkaido, 060-8648 Japan Japan
Telephone 011-706-5977
E-mail
Affiliation Hokkaido University Hospital Radiology Division